| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Journal of Virology, March 2008, p. 3131-3134, Vol. 82, No. 6
0022-538X/08/$08.00+0 doi:10.1128/JVI.02266-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Matthew B. Brecher,2,
Zaoying Chen,1
Deborah C. Melder,3
Mark J. Federspiel,3 and
Judith M. White1,2
Departments of Cell Biology,1 Microbiology and Immunology, The University of Virginia, Charlottesville, Virginia 22908,2 Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota 559053
Received 18 October 2007/ Accepted 20 December 2007
We previously showed that the cysteines flanking the internal fusion peptide of the avian sarcoma/leukosis virus subtype A (ASLV-A) Env (EnvA) are important for infectivity and cell-cell fusion. Here we define the stage of fusion at which the cysteines are required. The flanking cysteines are dispensable for receptor-triggered membrane association but are required for the lipid mixing step of fusion, which, interestingly, displays a high pH onset and a biphasic profile. Second-site mutations that partially restore infection partially restore lipid mixing. These findings indicate that the cysteines flanking the internal fusion peptide of EnvA (and perhaps by analogy Ebola virus glycoprotein) are important for the foldback stage of the conformational changes that lead to membrane merger.
Published ahead of print on 9 January 2008.
S.E.D. and M.B.B. contributed equally to this work.
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|